FUJISAWA USA INC (LYPHOMED INC) -- ARISTOSPAN 5 MG -- 6505-01-156-1663
===================== Product Identification ===================== Product ID:ARISTOSPAN 5 MG MSDS Date:01/01/1994 FSC:6505 NIIN:01-156-1663 === Responsible Party === Company Name:FUJISAWA USA INC (LYPHOMED INC) Address:3 PARKWAY NORTH City:DEERFIELD State:IL ZIP:60015-2548 Country:US Info Phone Num:800-727-7003/708-317-8800 Emergency Phone Num:708-317-8202 Preparer's Name:CHRISTINA J BARRINGTON CAGE:24832 === Contractor Identification === Company Name:FUJISAWA USA INC (LYPHOMED INC) Address:3 PARKWAY NORTH City:DEERFIELD State:IL ZIP:60015-2548 Country:US Phone:800-727-7003/708-317-8800 CAGE:24832 Company Name:FUJISAWA USA, INC Address:3 PKY N Box:City:DEERFIELD State:IL ZIP:60015-2548 Country:US Phone:847-317-1256 CAGE:39832 ============= Composition/Information on Ingredients ============= Ingred Name:BENZYL ALCOHOL CAS:100-51-6 RTECS #:DN3150000 Ingred Name:POLYSORBATE 80 USP, POLYOXYETHYLENESORBITOL OLEATE, TWEEN 80 CAS:9005-65-6 RTECS #:WG2932500 Ingred Name:SORBITOL CAS:50-70-4 RTECS #:LZ4290000 Ingred Name:TRIAMCINOLONE HEXACETONIDE CAS:5611-51-8 RTECS #:TU3930000 Ingred Name:WATER CAS:7732-18-5 RTECS #:ZC0110000 ===================== Hazards Identification ===================== Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO Health Hazards Acute and Chronic:IMMEDIATE EFFECTS: EYE, SKIN & MUCOUS MEMBRANE IRRITATION MAY OCCUR. DELAYED EFFECTS: PRIMARY IRRITATION OF SKIN/EYES, FLUID RETENTION, MUSCLE WEAKNESS, IMPAIRED WOUND HEALING, HEADACHE, VERTIGO & CON VULSIONS HAVE BEEN REPORTED W/PATIENT ADMINISTRATION. Explanation of Carcinogenicity:NONE Effects of Overexposure:IMMEDIATE EFFECTS: EYE, SKIN & MUCOUS MEMBRANE IRRITATION MAY OCCUR. DELAYED EFFECTS: PRIMARY IRRITATION OF SKIN/EYES, FLUID RETENTION, MUSCLE WEAKNESS, IMPAIRED WOUND HEALING, HEADACHE, VERTIGO & CON VULSIONS HAVE BEEN REPORTED W/PATIENT ADMINISTRATION. Medical Cond Aggravated by Exposure:PRE-EXISTING SKIN CONDITIONS. ======================= First Aid Measures ======================= First Aid:INHALTION: MOVE TO FRESH AIR. GIVE CPR IF REQUIRED. INGESTION: FLUSH MOUTH OUT W/WATER. SKIN: FLUSH AREA W/WATER FOR 15 MINS. EYES: FLUSH W/WATER FOR 15 MINS. OBTAIN MEDICAL ATTENTION IN ALL CASES. ===================== Fire Fighting Measures ===================== Flash Point Method:CC Flash Point: >200F Extinguishing Media:WATER SPRAY, DRY CHEMICAL, CO2, FOAM. Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS & PROTECTIVE CLOTHING. ================== Accidental Release Measures ================== Spill Release Procedures:WEAR RECOMMENDED PERSONAL PROTECTIVE EQUIPMENT. USE ABSORBENT TOWELS/BOOMS TO CLEAN UP. WIPE SURFACES CLEAN & WASH W/SOAP & WATER. ====================== Handling and Storage ====================== Handling and Storage Precautions:WHEN HANDLING PHARMACEUTICAL PRODUCTS, AVOID CONTACT/INHALATION OF DUST, FUMES, MIST/VAPORS ASSOCIATED W/PRODUCT. ============= Exposure Controls/Personal Protection ============= Respiratory Protection:NONE USUALLY REQUIRED W/SATISFACTORY VENTILATION. Ventilation:GENERAL ROOM USUALLY SATISFACTORY. LOCAL EXHAUST WHEN NECESSARY. Protective Gloves:DISPOSABLE LATEX Eye Protection:SAFETY GLASSES/GOGGLES Other Protective Equipment:DISPOSABLE GARMENTS Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE REUSE. Supplemental Safety and Health PH: 4.5-6.5. THIS PRODUCT IS INTENDED FOR THERAPEUTIC USE ONLY WHEN PRESCRIBED BY A PHYSICIAN. ================== Physical/Chemical Properties ================== pH:SUPP Solubility in Water:INSOLUBLE Appearance and Odor:CLEAR STERILE SOLUTION ================= Stability and Reactivity Data ================= Stability Indicator/Materials to Avoid:YES NONE Stability Condition to Avoid:NONE Hazardous Decomposition Products:SMOKE & FLUORINE FUMES ==================== Disposal Considerations ==================== Waste Disposal Methods:DISPOSE OF IAW/FEDERAL, STATE & LOCAL REGULATIONS. Disclaimer (provided with this information by the compiling agencies): This information is formulated for use by elements of the Department of Defense. The United States of America in no manner whatsoever, expressly or implied, warrants this information to be accurate and disclaims all liability for its use. Any person utilizing this document should seek competent professional advice to verify and assume responsibility for the suitability of this information to their particular situation.